Global Rotavirus Vaccines Market Global Analysis Overview Report 2018
Qurate Research announces the addition of new study based research report on “Rotavirus Vaccines Market” to their suite of offerings.
(EMAILWIRE.COM, October 13, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Rotavirus Vaccines Market Report for 2018-2023.
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, hand washing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-LPI-HnM-58928
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
Over the next five years, Expert projects that Rotavirus Vaccines will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017. This report presents a comprehensive overview, market shares, and growth opportunities of Rotavirus Vaccines market by product type, application, key manufacturers and key regions.
For Enquiry, Visit@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-LPI-HnM-58928
To calculate the market size, Expert considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Rotarix
RotaTeq
Rotavac
Others
Segmentation by application:
Adult
Pediatric
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Bharat Biotech
Merck & Co., Inc.
GlaxoSmithKline plc
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Direct Purchase@ https://www.qurateresearch.com/report/buy/HnM/QBI-LPI-HnM-58928/
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, hand washing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-LPI-HnM-58928
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
Over the next five years, Expert projects that Rotavirus Vaccines will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017. This report presents a comprehensive overview, market shares, and growth opportunities of Rotavirus Vaccines market by product type, application, key manufacturers and key regions.
For Enquiry, Visit@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-LPI-HnM-58928
To calculate the market size, Expert considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Rotarix
RotaTeq
Rotavac
Others
Segmentation by application:
Adult
Pediatric
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Bharat Biotech
Merck & Co., Inc.
GlaxoSmithKline plc
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Direct Purchase@ https://www.qurateresearch.com/report/buy/HnM/QBI-LPI-HnM-58928/
Contact Information:
Qurate Business Intelligence
Nehal Chinoy
Tel: +919881074592
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Qurate Business Intelligence
Nehal Chinoy
Tel: +919881074592
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results